Dry skin and impairment of barrier function associated with itch - New insights

International Journal of Cosmetic Science

Volumn 26, Issue 1, 2004, Pages 1-7

  Yosipovitch, G ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Itch; Neuropeptides; Serine protease; Stratum corneum

Indexed keywords

ACETONE; MUSCARINIC RECEPTOR; NERVE GROWTH FACTOR; OPIATE DERIVATIVE; PROTEIN FOS; PROTEINASE ACTIVATED RECEPTOR 2; SERINE PROTEINASE; TRYPTASE;

ATOPIC DERMATITIS; CENTRAL NERVOUS SYSTEM; CROSS LINKING; DRY SKIN; ECZEMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMIDIFIER; HYDRATION; IMMUNOREACTIVITY; NONHUMAN; PATHOPHYSIOLOGY; PRURITUS; REVIEW; SCRATCHING; SENILITY; SKIN FUNCTION; SKIN INFLAMMATION; SKIN PROTECTION; SKIN SENSATION; SKIN STIMULATION; STRATUM CORNEUM; SYMPTOM; TRANSGENIC MOUSE; UREMIA; WATER LOSS; XEROSIS;

EID: 1442303210     PISSN: 01425463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0142-5463.2004.00199.x     Document Type: Review

References (48)

1. Yosipovitch, G. Pruritus - an update. Curr. Probl. Dermatol. 15, 135-164 (2003).
2. Agner, T. Non-invasive measuring methods for the investigation of irritant patch test reactions. A study of patients with hand eczema, atopic dermatitis and controls. Acta Derm. Venereol. 173 (Suppl.), 1-26 (1992).
3. Seidenari, S. and Giusti, G. Objective assessment of the skin of children affected by atopic dermatitis. A study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm. Venereol. 75, 429-433 (1995).
4. Werner, Y. and Lindberg, M. Transepidermal water loss in dry nas clinically normal skin in patients with atopic dermatitis. Acta Derm. Venereol. 65, 102-105 (1985).
5. Fleischer, A.B. Pruritus in the elderly, management by senior dermatologists. J. Am. Acad. Dermatol. 28, 603-609 (1993).
6. Long, C.C. and Marks, R. Stratum corneum changes in patients with senile pruritus. J. Am. Acad. Dermatol. 27, 560-564 (1992).
7. Guillet, G., Zampetti, A., Czarlewski, W. and Guillet, M.H. Increased histamine release and skin hypersensitivity to histamine in senile pruritus. study of 60 patients. J. Eur. Derm. Venereol. 14, 65-68 (2000).
8. Bencini, P.L., Montagnino, G., Citterio, A. et al. Cutaneous abnormalities in uremic patients. Nephron 40, 316-321 (1985).
9. Young, A.W., Sweeney, E.W., Davis, D.S. et al. Dermatologic evaluation of pruritus in patients on haemodialysis. N Y State J. Med. 73, 2670-2674 (1973).
10. Stahle-Backdahl, M. Uremic pruritus. Clinical and experimental studies. Acta Derm Venereol (Suppl.) (Stockh). 145, 1-38 (1989).
11. Yosipovitch, G., Reis, J., Tur, E. et al. Sweat secretion, stratum corneum hydration, small nerve function and pruritus in patients with advanced chronic renal failure. Br. J. Dermatol. 133, 561-564 (1995).
12. Yosipovitch, G., Tur, E., Morduchowicz, G. and Boner, G. Skin surface pH, moisture, and pruritus in haemodialysis patients. Nephrol. Dial. Transplant. 8, 1129-1132 (1993).
13. Fluhr, J.W., Kao, J., Jain, M. et al. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J. Invest Dermatol. 117, 44-51 (2001).
14. Hachem, J.P., Crumrine, D., Fluhr, J. et al. pH directly regulates epidermal permeability barrier homeostasis and stratum corneum integrity cohesion. J. Invest. Dermatol. 121, 345-353 (2003).
15. Kato, A., Hamada, M., Maruyama, T. et al. Pruritus and hydration state of stratum corneum in hemodialysis patients. Am. J. Nephrol. 20, 437-442 (2000).
16. Tagami, H., Kanamaru, Y., Inoue, K. et al. Water sorption-desorption test of the skin in vivo for functional assessment of the stratum corneum. J. Invest. Dermatol. 78, 425-428 (1982).
17. Szepietowski, J.C., Sikora, M., Kusztal, M., Salomon, J., Magott, M., and Szepietowski, T. Uremic pruritus: a clinical study of maintenance hemodialysis patients. J. Dermatol. 20, 621-627 (2002).
18. Uthayakumar, S., Nadwani, R., Drinkwater, T. et al. The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression. Br. J. Dermatol. 137, 595-598 (1997).
19. Rowe, A., Mallon, E., Rosenberger, P. et al. Depletion of cutaneous peptidergic innervation in HIV associated xerosis. J. Invest. Dermatol. 112, 284-289 (1999).
20. Calsita, D. and Boschini, A. Cutaneous side effects induced by indinavir. Eur. J. Dermatol. 10, 292-296 (2000).
21. Elias, P.M. and Ghadially, R. The aged epidermal permeability barrier: basis for functional abnormalities. Clin. Geriatr. Med. 18, 103-120 (2002).
22. Miyamaoto, T., Nojima, H. and Shinkado, T. et al. Itch-associated response induced by experimental dry skin in mice. Jpn. J. Pharmacol. 88, 285-292 (2002).
23. Denda, M., Sato, J., Tsuchiya, T. et al. Low humidity stimulates epidermal DNA synthesis and amplifies the hyperproliferative response to barrier disruption: implication for seasonal exacerbations of inflammatory dermatoses. J. Invest. Dermatol. 111, 873-878 (1998).
24. Ashida, Y. and Denda, M. Dry environment increases mast cell number and histamine content in dermis in hairless mice. Br. J. Dermatol. 149, 240-247 (2003).
25. Nojima, H., Carstens, M.I. and Carstens, E. C-fos expression in superficial dorsal horn of cervical spinal cord associated with spontaneous scratching in rats with dry skin. Neurosci. Lett. 347, 62-64 (2003).
26. Chi, S.I., Levine, J.D. and Basbaum, A.I. Peripheral and central contributions to the persistent expression of spinal cord fos-like immunoreactivity produced by sciatic nerve transection in the rat. Brain Res. 617, 225-237 (1993).
27. Andrew, D. and Craig, A.D. Spinothalamic lamina 1 neurons selectively sensitive to histamine: a central neural pathway for itch. Nat. Neurosci. 4, 72-77 (2001).
28. Schmelz, M., Schmidt, R., Bickel, A. et al. Specific C-receptors for itch in human skin. J. Neurosci. 17, 8003-8008 (1997).
29. Schmelz, M., Hilliges, M., Schmidt R. et al. Active 'itch fibers' in chronic pruritus. Neurology 61, 564-566 (2003).
30. Metze, D., Reimann, S., Beissert, S. and Luger, T. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J. Am. Acad. Dermatol. 41, 533-539 (1999).
31. Bigliardi-Qi, M., Bigliardi, P.L., Buchner, S. and Rufli, T. Characterization of mu-opiate receptor in human epidermis and keratinocytes. Ann. N Y Acad. Sci. 885, 368-371 (1999).
32. Takamori, K., Takimoto, R. and Hase, T. Mechanisms of itch in dry skin - NGF induces the elongation/penetration of nerve fibers into the epidermis. In: Proceedings of the International Workshop for the Study of Itch, Singapore, p. 36 (2001).
33. Miyamoto, T., Nojima, H., Nakahashi, T. and Kuraishi, Y. Involvement of cutaneous ACH and M3 muscarinic ACH receptors in dry skin-associated pruritus in mice. In: Proceedings of the Second International Workshop for the Study of Itch, Toyoma, Japan, p. 61 (2003).
34. Wessler, I., Reinheimer, T., Kilbinger, H. et al. Increased acetylcholine levels in skin biopsies of patients with atopic dermatitis. Life Sci. 72, 2169-2172 (2003).
35. Hansson, L., Backman, A., Ny, A. et al. Epidermal over expression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis. J. Invest. Dermatol. 118, 444-449 (2002).
36. Ekholm, E. and Egelrud, T. Stratum corneum chymotryptic enzyme in psoriasis. Arch. Dermatol. Res. 291, 195-200 (1999).
37. Chan, L.S., Robinson, N. and Xu, L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J. Invest. Dermatol. 117, 977-983 (2001).
38. Steinhoff, M., Neisius, U., Ikoma, A. et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J. Neurosci. 16, 6176-6180 (2003).
39. Denda, M., Kitamura, K., Elias, P.M. and Feingold, K.R. trans-4-(Aminomethyl)cyclohexane carboxylic acid (T-AMCHA), an anti-fibrinolytic agent, accelerates barrier recovery and prevents the epidermal hyperplasia induced by epidermal injury in hairless mice and humans. J. Invest. Dermatol. 109, 84-90 (1997).
40. Denda, M., Fuziwara, K., Inoue, S. et al. Immunoreactivity of VR1 on epidermal keratinocyte of human skin. Biochem. Biophys. Res. Commun. 285, 1250-1252 (2001).
41. Denda, M. New strategies to improve barrier homeostasis. Adv. Drug Deliv. Rev. 54, S123-S130 (2002).
42. Stander, S. and Steinhoff, M. Pathophysiology of pruritus in atopic dermatitis: an overview. Exp. Dermatol. 11, 12-24 (2002).
43. Yosipovitch, G., Greaves, M. and Schmelz, M. Itch Lancet 361, 690-694 (2003).
44. Mao-Qiang, M., Feingold, K.R. and Elias, P.M. Exogenous lipids influence permeability barrier recovery in acetone treated murine skin. Arch. Dermatol. 129, 728-738 (1993).
45. Man, M.M., Feingold, K.R., Thornfeldt, C.R. and Elias, P.M. Optimization of physiological lipid mixtures for barrier repair. J. Invest. Dermatol. 106, 1096-1101 (1996).
46. Chamlin, S.L., Kao, J., Frieden, I. et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J. Am. Acad. Dermatol. 47. 198-208 (2002).
47. Imokawa, G. Lipid abnormalities in atopic dermatitis. J. Am. Acad. Dermatol. 45 (Suppl.), S29-S32 (2001).
48. Freitag, G. and Hoppner, T. Results of a postmarketing drug monitoring survey with a polidocanol-urea preparation for dry, itching skin. Curr. Med. Res. Opin. 13, 529-537 (1997).